Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. BNTC.NASDAQ

Benitec Biopharma Ltd ADR (BNTC NASDAQ) stock market data APIs

$9.251 -0.15(-1.6%) as of July 26, 2024
Price chart is built with Anychart

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

Benitec Biopharma Ltd ADR Financial Data Overview

9.4
9.251
-
9.71
9.251
1.86-10.88
86 659 K
9 367 K
7 000
-1.64
0.915
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BNTC',
Type: 'Common Stock',
Name: 'Benitec Biopharma Ltd ADR',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00R712L56',
ISIN: NULL,
CUSIP: NULL,
CIK: '1808898',
EmployerIdNumber: '',
FiscalYearEnd: 'June',
IPODate: '2015-08-18',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR Primary',
IsDelisted: false,
}

Benitec Biopharma Ltd ADR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 7 000
  • EBITDA -21 410 000
  • Earnings Per Share -9.6
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Benitec Biopharma Ltd ADR Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.78

Get Benitec Biopharma Ltd ADR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Benitec Biopharma Ltd ADR latest news via APIs

11 Best ASX Stocks To Buy Now

In this piece, we will take a look at the 11 best ASX stocks to buy now. If you want to skip our introduction to the Australian stock market, then you can take a look at the 5 Best ASX Stocks To Buy N...

Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy

HAYWARD, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developin...
  • BENITEC BIOPHARMA INC
  • CLINICAL STUDY
  • NASDAQ:BNTC
Do you have any questions?
support@eodhistoricaldata.com